Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alk-Abello ASCHIX:ALKBC 92 3-Year Book Growth Rate is 17.30% as of Jun. 2026, which is 268% above its 10-year median of 4.70. GuruFocus rates CHIX:ALKBC with a GF Score™ of 92/100 and a GF Value™ of kr229.65 (Fairly Valued). Among 1,121 Biotechnology companies, Alk-Abello AS ranks better than 83.05% on this metric.
During the past 12 months, Alk-Abello AS's average Book Value per Share Growth Rate was 18.60% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 17.30% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 15.00% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 6.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Alk-Abello AS was 17.30% per year. The lowest was -32.70% per year. And the median was 4.70% per year.
Alk-Abello AS (CHIX:ALKBc) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Alk-Abello AS 3-Year Book Growth Rate Related Terms
CHIX:ALKBC vs VRTX, REGN, MRNA: 3-Year Book Growth Rate Comparison
For the Biotechnology subindustry, Alk-Abello AS's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alk-Abello AS 3-Year Book Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alk-Abello AS's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Alk-Abello AS's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 17.30% mean?
Alk-Abello AS (CHIX:ALKBC) has a 3-Year Book Growth Rate of 17.30% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Alk-Abello AS and its competitors. This is 268% above median its historical median of 4.70. According to the industry distribution chart, Alk-Abello AS ranks #190 out of 1121 companies in the Biotechnology industry, placing it in the top 16.9%.
Is Alk-Abello AS's 3-Year Book Growth Rate too high?
Alk-Abello AS's current 3-Year Book Growth Rate of 17.30% is 268% above median its 10-year median of 4.70. Based on the distribution chart, Alk-Abello AS ranks #190 out of 1121 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Alk-Abello AS has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's 3-Year Book Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alk-Abello AS ranks #190 out of 1121 companies for 3-Year Book Growth Rate. This places Alk-Abello AS in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Alk-Abello AS and its competitors. Alk-Abello AS's current 3-Year Book Growth Rate is 17.30%, which is 268% above median its own 10-year median of 4.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (CHIX:ALKBC) is currently considered Fairly Valued. The stock's GF Value™ is kr229.65, compared to a current price of kr221.50 — trading 3.5% below its estimated fair value. The current 3-Year Book Growth Rate is 17.30%, which is 268% above median its 10-year median of 4.70. Alk-Abello AS's overall GF Score™ is 92/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Alk-Abello AS (CHIX:ALKBC), the current 3-Year Book Growth Rate is 17.30% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?
Based on GuruFocus' analysis, Alk-Abello AS stock appears to be undervalued.
The current stock price of kr221.50 is trading 3.5% below its estimated GF Value™ of kr229.65.
GuruFocus considers Alk-Abello AS to be Fairly Valued.
Key valuation signals for CHIX:ALKBC:
3-Year Book Growth Rate: 17.30% (268% above median its 10-year median of 4.70)
GF Value™: kr229.65 vs. price of kr221.50 (3.5% below fair value)
No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
92GF Score
Get the complete analysis for CHIX:ALKBC
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ALKBC has been successfully added to your 
